chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Nausea, Vomiting
Clinical narrative: Sweating; Feeling nauseous; Vomited; Slight headache; This is a spontaneous report from a non-contactable consumer, the patient. A 21-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03Sep2021 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, allergy to penicillin and plums. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included paroxetine hydrochloride (PAXIL) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received meningococcal vaccine (reported as meningitis) (MANUFACTURER UNKNOWN) on 20Jul2021 for meningitis. On 04Sep2021 at 11:00 in the morning, the patient started sweating, feeling nauseous, then vomited and currently had a slight headache. The events did not result in doctors or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sweating, feeling nauseous, vomited and slight headache were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dyspnoea, Erythema, Headache
Clinical narrative: Headache; Diarrhea; Nausea; Vomiting; Chills; Fever; Shortness of breath; Racing heart; Pain swelling and redness in arm of injection; Pain swelling and redness in arm of injection; Pain swelling and redness in arm of injection; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Sep2021 at 12:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine, overactive bladder (OAB) and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included erenumab aooe (AIMOVIG) and mirabegron (MYRBETRIQ); all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Jul2021 at 09:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 02Sep2021 at 02:00, the patient experienced headache, diarrhea, nausea, vomiting, chills, fever, shortness of breath, racing heart, pain, swelling and redness in arm of injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with acetaminophen (TYLENOL), ranitidine (ZANTAC), sumatriptan (IMITREX) and diphenhydramine (BENADRYL). The clinical outcome of the events headache, diarrhea, nausea, vomiting, chills, fever, shortness of breath, racing heart, pain, swelling and redness in arm of injection were resolving at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Palpitations, Peripheral swelling, Pyrexia
Clinical narrative: Headache; Diarrhea; Nausea; Vomiting; Chills; Fever; Shortness of breath; Racing heart; Pain swelling and redness in arm of injection; Pain swelling and redness in arm of injection; Pain swelling and redness in arm of injection; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Sep2021 at 12:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine, overactive bladder (OAB) and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included erenumab aooe (AIMOVIG) and mirabegron (MYRBETRIQ); all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Jul2021 at 09:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 02Sep2021 at 02:00, the patient experienced headache, diarrhea, nausea, vomiting, chills, fever, shortness of breath, racing heart, pain, swelling and redness in arm of injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with acetaminophen (TYLENOL), ranitidine (ZANTAC), sumatriptan (IMITREX) and diphenhydramine (BENADRYL). The clinical outcome of the events headache, diarrhea, nausea, vomiting, chills, fever, shortness of breath, racing heart, pain, swelling and redness in arm of injection were resolving at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Headache; Diarrhea; Nausea; Vomiting; Chills; Fever; Shortness of breath; Racing heart; Pain swelling and redness in arm of injection; Pain swelling and redness in arm of injection; Pain swelling and redness in arm of injection; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Sep2021 at 12:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine, overactive bladder (OAB) and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included erenumab aooe (AIMOVIG) and mirabegron (MYRBETRIQ); all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Jul2021 at 09:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 02Sep2021 at 02:00, the patient experienced headache, diarrhea, nausea, vomiting, chills, fever, shortness of breath, racing heart, pain, swelling and redness in arm of injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with acetaminophen (TYLENOL), ranitidine (ZANTAC), sumatriptan (IMITREX) and diphenhydramine (BENADRYL). The clinical outcome of the events headache, diarrhea, nausea, vomiting, chills, fever, shortness of breath, racing heart, pain, swelling and redness in arm of injection were resolving at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea
Clinical narrative: Felt tightening of the chest; Couldn't breathe; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on 01Sep2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unknown date in Sep2021, the patient felt tightening of the chest and could not breathe. The clinical outcome of the events felt tightening of the chest and could not breathe was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Malaise, Pain in extremity, Rash
Clinical narrative: Rash all along left arm, upper arm, chest, shoulder and neck; Rash was red and hot; Rash was red and hot; Severe arm pain; Headache; Felt ill, like the flu; Felt ill, like the flu; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 26-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 27Aug2021 (at the age of 26-year-old), as a single dose for COVID-19 immunisation. Medical history included hashimoto's, Antinuclear Antibodies (ANA) positive and migraine disorder from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), zonisamide (ZONEGRAN), rizatriptan benzoate (MAXALT), rimegepant sulfate (NURTEC ODT) and ibuprofen (ADVIL); all for unspecified indication from unknown date and unknown if ongoing. The patient previously received morphine (MANUFACTURER UNKNOWN) for unspecified indication from unknown date and experienced drug allergy. On 27Aug2021, the patient experienced rash all along left arm, upper arm (did not included the area near injection), chest, shoulder and stopping at the neck. The patient was unsure when the rash was started as the patient had a sweatshirt on after the vaccination and it was noticed by the patients husband 3-4 hours after the vaccine. Rash grew for 4-6 hours and then dissipated. The patient described rash was red and hot but not itchy. The rash was accompanied by severe arm pain and a headache. On 27Aug2021, the patient also felt ill, like had flu which had continued for seven plus days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 31Aug2021, the patient underwent nasal swab test and the result was negative. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events rash all along left arm, upper arm, chest, shoulder and neck, rash was red and hot, severe arm pain, headache and felt ill, like the flu was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, SARS-CoV-2 test, Skin warm
Clinical narrative: Rash all along left arm, upper arm, chest, shoulder and neck; Rash was red and hot; Rash was red and hot; Severe arm pain; Headache; Felt ill, like the flu; Felt ill, like the flu; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 26-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 27Aug2021 (at the age of 26-year-old), as a single dose for COVID-19 immunisation. Medical history included hashimoto's, Antinuclear Antibodies (ANA) positive and migraine disorder from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), zonisamide (ZONEGRAN), rizatriptan benzoate (MAXALT), rimegepant sulfate (NURTEC ODT) and ibuprofen (ADVIL); all for unspecified indication from unknown date and unknown if ongoing. The patient previously received morphine (MANUFACTURER UNKNOWN) for unspecified indication from unknown date and experienced drug allergy. On 27Aug2021, the patient experienced rash all along left arm, upper arm (did not included the area near injection), chest, shoulder and stopping at the neck. The patient was unsure when the rash was started as the patient had a sweatshirt on after the vaccination and it was noticed by the patients husband 3-4 hours after the vaccine. Rash grew for 4-6 hours and then dissipated. The patient described rash was red and hot but not itchy. The rash was accompanied by severe arm pain and a headache. On 27Aug2021, the patient also felt ill, like had flu which had continued for seven plus days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 31Aug2021, the patient underwent nasal swab test and the result was negative. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events rash all along left arm, upper arm, chest, shoulder and neck, rash was red and hot, severe arm pain, headache and felt ill, like the flu was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Nausea, Pyrexia, Urinary tract infection
Clinical narrative: Urinary Tract Infection; Extreme fatigue; Fever; Nausea; Diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 27Aug2021 at 18:00 (at the age of 33-years old) as a single dose for COVID-19 immunisation. Medical history included factor V Leiden, asthma, chronic bronchitis and psoriasis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received measles vaccine/ mumps vaccine/ rubella vaccine (MMR) and experienced reaction to MMR vaccine. On 27Aug2021 at 23:00, the patient experienced urinary tract infection, extreme fatigue, fever, nausea and diarrhea. The events resulted in emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measure was taken as a result of the events which included treatment with sulfamethoxazole/ trimethoprim (BACTRIM). The clinical outcome of the events urinary tract infection, extreme fatigue, fever, nausea and diarrhea were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swelling of lymph nodes in armpit same side of injection 2 days after; This is a spontaneous report from a contactable healthcare professional, the patient. A 47-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 01Sep2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. On 03Sep2021, 2 days after the vaccination at same side of injection, the patient experienced swelling of lymph nodes in armpit. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swelling of lymph nodes in armpit same side of injection 2 days after was unknown at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Extremely tired for a day and 1/2. Could only stand and/or walk for about 5 minutes and then had to go and lay down; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration on an unknown date in Aug2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified over the counter sleeping pills of 50 mg. On 15Aug2021, the patient experienced extremely tired for a day and half. The patient reported that she could only stand and or walk for about 5 minutes and then had to go and lay down. The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event extremely tired for a day and 1/2 and could only stand and/or walk for about 5 minutes and then had to go and lay down was recovered on an unknown date in Aug2021.  No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac flutter, Chest pain, Palpitations
Clinical narrative: fast and pounding/fluttering heart beat; Chest pain; heart palpitations; This is a spontaneous report from a contactable consumer (patient). This 49-year-old female patient (non-pregnant at time of vaccination) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the Arm Left on 13Aug2021 (at the age of 49-year-old; lot number: FC3180) as DOSE 1, SINGLE for COVID-19 immunization. Medical history included known allergies of shellfish, asthma and allergies. No covid prior vaccination. No covid tested post vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any other medications within 2 weeks of vaccination. There were no concomitant medications. On unspecified date, the patient experienced chest pain, heart palpitations, fast and pounding/fluttering heart beat. The events resulted in Emergency room/department or urgent care. Treatment received for events. Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, has the patient did not test for COVID-19. Outcome of events was unknown.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Almost died with it, she got so sick; This is a spontaneous report from a contactable consumer. This is the second case out of two cases in which consumer reported for a female patient (brother's wife). A female patient of an unspecified age received bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot number was not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced almost died with it, she got so sick. It was reported that "I had my first dose, Pfizer shot here almost three weeks ago and I am due for the second one in two days and I am really concerned about it because I did, not immediately had a reaction but within 24 hours, I ended up with severe chills that lasted for about 2 days and I had chills off and on, I mean we had 90 degree weather and I could not stand having the fan blowing or like just air conditioner on. I just didn't feel good at all, it made me feel, I just wonder and voice was not clear, I am an elderly person and usually pretty healthy but I am kind of concerned about going for the second shot with that kind of a reaction on the first one. My friends had the shot (Shot name not clarified, hence suspect captured as Unspecified Shot), my brother and his wife, his wife got, almost died with it, she got so sick. I am just feared you know. Also, my right leg, especially my ankle and foot are just been swelling more than normal, to more than, it was really tight". The clinical outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Swelling face, Tremor
Clinical narrative: 29 hours after shot, had an allergic reaction; Throat did not close but the whole face swole up; Could not stop shaking; This is a spontaneous report from a non-contactable consumer, the patient. A 17-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Aug2021 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to tree nuts, anaphylactic. The patient always carried a epinephrine (EPIPEN). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 29Aug2021, 29 hours after the shot, the patient experienced an allergic reaction. The patient's throat did not close but whole face was swollen up and the patient could not stop shaking. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events allergic reaction, throat did not close but the whole face swole up and could not stop shaking were recovered on an unknown date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Malaise
Clinical narrative: Feeling unwell; Fatigue; This is a spontaneous report from a contactable consumer (Pfizer employee). An elderly non-pregnant female patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 02Sep2021 at 10:00 as a single dose for COVID-19 immunisation. It was unknown if the patient had any medical history and known allergies. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown whether the patient had received any other vaccines within four weeks prior to the COVID vaccine. It was unknown if the patient received any concomitant medications. On 03Sep2021, the patient was feeling unwell and experienced fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events feeling unwell and fatigue was resolving at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Discomfort, Fatigue, Illness
Clinical narrative: Migraine; Chills; Aches were pronounced on chest and neck, up into jaw; Aches were pronounced on chest and neck, up into jaw; Aches were pronounced on chest and neck, up into jaw; Extremely uncomfortable; Feeling muscle aches, especially around chest; Extremely tired; Like getting sick tired; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration in the left arm on 30Aug2021 at 09:45 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included triamcinolone acetonide (NASACORT) and fexofenadine hydrochloride (ALLEGRA); both for an unknown indications from an unknown dates and unknown if ongoing. On 30Aug2021 (first day), the patient was extremely tired, like getting sick tired. On 31Aug2021 (second day), the patient felt great. On 01Sep2021 (third day) at 14:00, the patient started feeling muscle aches, especially around chest. On 02Sep2021 (fourth day), the aches were pronounced on chest and neck, up into the jaw, to the point that the patient was extremely uncomfortable. On 03Sep2021 (fifth day), the patient had a migraine, along with muscle aches. The patient had no fever but had chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events extremely tired and like getting sick tired were resolving while that of events feeling muscle aches, especially around chest, aches were pronounced chest and neck, up into jaw, extremely uncomfortable, migraine and chills were not recovered at the time of this report.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Myalgia, Neck pain, Pain in jaw
Clinical narrative: Migraine; Chills; Aches were pronounced on chest and neck, up into jaw; Aches were pronounced on chest and neck, up into jaw; Aches were pronounced on chest and neck, up into jaw; Extremely uncomfortable; Feeling muscle aches, especially around chest; Extremely tired; Like getting sick tired; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration in the left arm on 30Aug2021 at 09:45 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included triamcinolone acetonide (NASACORT) and fexofenadine hydrochloride (ALLEGRA); both for an unknown indications from an unknown dates and unknown if ongoing. On 30Aug2021 (first day), the patient was extremely tired, like getting sick tired. On 31Aug2021 (second day), the patient felt great. On 01Sep2021 (third day) at 14:00, the patient started feeling muscle aches, especially around chest. On 02Sep2021 (fourth day), the aches were pronounced on chest and neck, up into the jaw, to the point that the patient was extremely uncomfortable. On 03Sep2021 (fifth day), the patient had a migraine, along with muscle aches. The patient had no fever but had chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events extremely tired and like getting sick tired were resolving while that of events feeling muscle aches, especially around chest, aches were pronounced chest and neck, up into jaw, extremely uncomfortable, migraine and chills were not recovered at the time of this report.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Headache, Inappropriate schedule of product administration, Pain
Clinical narrative: Severe persistent headache; Chills; Body aches; Cough accompanied by throbbing headache; Cough accompanied by throbbing headache; Dose 1: 09Apr2021; Dose 2: 01Sep2021; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 01Sep2021 at 12:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included unspecified allergies and known allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 09Apr2021 at 08:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. On 01Sep2021 at 20:00, the patient experienced severe persistent headache, chills, body aches, and cough accompanied by throbbing headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with paracetamol (TYLENOL). The clinical outcome of the events severe persistent headache, chills, body aches, and cough accompanied by throbbing headache were not recovered at the time of this report.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Fatigue, Headache, Hypoaesthesia
Clinical narrative: SOB; Chest pain (especially when inhaling); Numbness in left arm; Pain/feeling sore in extremities; Tiredness; Headache; Vomiting (once); This is a spontaneous report from a non-contactable healthcare professional, the patient. A 31-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Aug2021 at 17:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines with aura, allergies to penicillin and sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. On 31Aug2021, the patient experienced shortness of breath (SOB), chest pain (especially when inhaling), numbness in left arm, tiredness, pain/feeling sore in extremities, headache and vomiting (once). Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events shortness of breath (SOB), chest pain (especially when inhaling), numbness in left arm, tiredness, pain/feeling sore in extremities, headache and vomiting (once) were not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vomiting
Clinical narrative: SOB; Chest pain (especially when inhaling); Numbness in left arm; Pain/feeling sore in extremities; Tiredness; Headache; Vomiting (once); This is a spontaneous report from a non-contactable healthcare professional, the patient. A 31-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Aug2021 at 17:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines with aura, allergies to penicillin and sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. On 31Aug2021, the patient experienced shortness of breath (SOB), chest pain (especially when inhaling), numbness in left arm, tiredness, pain/feeling sore in extremities, headache and vomiting (once). Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events shortness of breath (SOB), chest pain (especially when inhaling), numbness in left arm, tiredness, pain/feeling sore in extremities, headache and vomiting (once) were not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Tasted metal or a metallic taste in mouth; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 26Feb2021 at 14:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the left arm on 05Feb2021 at 17:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 26Feb2021 at 14:30, within 5-6 seconds after the second dose of injection, the patient tasted metal or experienced a metallic taste in the mouth. The metallic taste was strong for 2-3 days following the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event tasted metal or a metallic taste in mouth was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Eye pruritus, Ocular hyperaemia, Periorbital swelling
Clinical narrative: Red eyes; Puffy, tender, itchy around the eyes; Puffy, tender, itchy around the eyes; Itchy around the eyes/eyeballs itchy; This is a spontaneous report from a non-contactable consumer, the patient. A 13-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 30Aug2021 at 14:45 (at the age of 13-years-old) as a single dose for COVID-19 immunisation. Medical history included epilepsy. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 30Aug2021 at 16:30, within hours of vaccine, the patient experienced red eyes, puffy, tender and itchy around eyes and after 36 hours, the patient experienced eyeballs itchy. The symptoms did not subside until over 55 hours after vaccination. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events red eyes, puffy, tender, itchy around the eyes and itchy around the eyes/eyeballs were itchy were resolved on an unknown date in Sep2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Pulmonary mass, SARS-CoV-2 test
Clinical narrative: Additional micronodule in the mid aspect of the left upper lobe, a left upper lobe micronodule posteriorly, and a punctate micronodule mid aspect of the left lower lobe superior segment.; This is a spontaneous report from a contactable consumer (pfizer colleague) reporting for the patient. A non-pregnant adult female patient of unknown age received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an intramuscular route of administration in the left arm on 23Mar2021 as a single dose for COVID-19 immunisation. Medical history included hypercholesterolemia and on 20Jan2021, lung nodule identified which was ongoing at the time of the report. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient had no known allergies. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an intramuscular route of administration in the left arm on 04Mar2021 as a single dose for COVID-19 immunisation. On 02Sep2021, the patient underwent lab tests and procedures which included a follow-up computerized tomography (CT) scan for a pulmonary nodule that was identified prior to COVID-19 vaccine on 20Jan2021. On 06Sep201, test results were received by the patient that revealed an additional micronodule in the mid aspect of the left upper lobe, a left upper lobe micronodule posteriorly and a punctate micronodule mid aspect of the left lower lobe superior segment. No additional pulmonary nodularity was identified and the original nodule identified on 20Jan2021 was unchanged. No other abnormalities noted. The patient was not symptomatic. The adverse event did not result in a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in Apr2021 the patient underwent COVID-19 test via nasal swab and the results were negative. The clinical outcome of the event additional micronodule in the mid aspect of the left upper lobe, a left upper lobe micronodule posteriorly and a punctate micronodule mid aspect of the left lower lobe superior segment was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Peripheral swelling
Clinical narrative: Swelling and discomfort under my right arm; Swelling and discomfort under my right arm; This is a spontaneous report from a contactable consumer, the patient. An elderly non-pregnant female patient of unknown age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD8448) via an unspecified route of administration in the right arm on 05Sep2021 at 12:30 as a single dose for COVID-19 immunisation. Medical history included high blood pressure (BP), cholesterol and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included valsartan (MANUFACTURER UNKNOWN), rosuvastatin calcium (CRESTOR) and unspecified vitamins; all for unknown indications from unknown dates and unknown if ongoing. On 07Sep2021 at 06:00, the patient experienced swelling and discomfort under right arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling and discomfort under right arm were recovering at the time of this report.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, COVID-19, Drug ineffective, Nasopharyngitis, SARS-CoV-2 antibody test
Clinical narrative: Received a positive covid rapid test less than 6 months after receiving the covid vaccine. My symptoms were head cold like at first then stopped smelling.; Received a positive covid rapid test less than 6 months after receiving the covid vaccine. My symptoms were head cold like at first then stopped smelling.; Received a positive covid rapid test less than 6 months after receiving the covid vaccine. My symptoms were head cold like at first then stopped smelling.; Received a positive covid rapid test less than 6 months after receiving the covid vaccine. My symptoms were head cold like at first then stopped smelling.; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient). A 27-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Lot Number: EP6955) via an unspecified route of administration (age at vaccination 27-year) in left arm on 22Mar2021 as dose number unknown, single for COVID-19 immunization at workplace clinic. Medical history included pregnancy (Pregnant currently) from an unknown date, High BP, over 40 BMI, from an unknown date and unknown if ongoing. Concomitant medications included bupropion hydrochloride (WELLBUTRIN); hydrochlorothiazide; ascorbic acid, betacarotene, biotin, calcium carbonate, calcium pantothenate, chromium, colecalciferol, copper, cyanocobalamin, ferrous fumarate, folic acid, magnesium oxide, manganese, nicotinamide, potassium iodide, pyridoxine hydrochloride, riboflavin, selenium, thiamine hydrochloride, tocopheryl acetate, zinc (PRENATAL [ASCORBIC ACID; BETACAROTENE; BIOTIN; CALCIUM CARBONATE; CALCIUM PANTOTHENATE; CHROMIUM; COLECALCIFEROL; COPPER; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID;MAGNESIUM OXIDE;MANGANESE; NICOTINAMIDE;POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN); all taken for an unspecified indication, start and stop date were not reported. The patient previously took Cyclogel eye drops and experienced allergies. The patient did not take any other vaccine in four weeks. The patient did not have COVID prior vaccination. The patient tested positive COVID after vaccination. On 30Aug2021, the patient received a positive COVID rapid test less than 6 months after receiving the COVID vaccine, her symptoms were head cold like at first then stopped smelling. The patient received no treatment for the adverse events. The patient underwent lab tests and procedures on 02Sep2021 which included SARS-COV-2 antibody test: positive (Nasal swab). The clinical outcome of the events was resolving.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Vertigo; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Aug2021 at 17:00 (at the age of 48-year-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication included metformin (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Aug2021 at 16:45 (at the age of 48-year-old), as a single dose for COVID-19 immunisation. On 29Aug2021 at 07:00, the patient experienced vertigo. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event vertigo was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Tingling, in both feet legs/ Tingling, right hand.; Numbness in right fingers.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 31Aug2021 at 13:45 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN) and amfepramone hydrochloride (DIETHYLPROPION); both for an unknown indication from an unknown date and unknown if ongoing. On 31Aug2021 at 19:00, the patient experienced tingling in both feet legs, right hand and numbness in right fingers. The events resulted in doctors or other healthcare professional office/clinic visit. It was unknown whether therapeutic measures were taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingling in both feet legs, right hand and numbness in right fingers were not resolved at the time of this report.